Reportlinker.com announces that a new market research report is available in its catalogue.

Reportlinker Adds Top 10 Medical Device Technology

Report description

Technological innovations in the medical device industry have led to a radical transformation in patient care. This report identifies the sectors with the industry's most important developments related to patient care, clinical outcomes, and new product development. While the scope of the report is limited to the top ten technologies only, it covers almost the entire medical device market.

Scientific and medical technology breakthroughs -- such as minimally invasive surgery (MIS) -- have accelerated the accuracy of clinical outcomes and have also reduced recovery times and the medical costs borne by patients. This has led to radical transformation in patient care.

IT integration in medical imaging and medical devices has given a significant boost to the healthcare industry, a trend that is apparent in the market growth of drug eluting stents and telemedicine technologies. The markets covered in the report have a current potential of $454.3 billion and are expected to grow at a CAGR of 9.8% between 2009 and 2014.

Market estimates and forecast

The report provides in-depth market estimates and forecast for top ten medical device technologies as follows:

* Diagnostic imaging (nuclear imaging, interventional radiology, capsule endoscopy and others)

* Drug delivery (needle free injections, transdermal systems, inhalation system, infusion system)

* Molecular diagnostics (biosensors, proteomics, nanotechnology, and others)

* Mobility aid technologies

* Minimal/non-invasive surgery (stents, bariatric surgery, medical robotics and others)

* Micro-fluids and MEMS (Miniature medical pressure sensors, bio chips, protein chips)

* Non-invasive monitoring (continuous blood glucose monitoring)

* Biomaterials (bionic limbs, joint replacement, antimicrobial wound dressing and others)

* Bio-implants (neurostimulation and others)

* Tele-medicines

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide more than 100 market tables for various geographic regions covering the sub-segments and micro-markets. In addition, the report also provides 50 company profiles for each of its sub-segments.

What makes our reports unique?

* We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.

* Each report is about 250 pages with 100+ market data tables, 40 competitive company profiles, analysis of 300 patents and minimum 50 micro markets, which are collectively exhaustive and mutually exclusive.

* No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, and stakeholders in a single report for all the four geographies - US, Europe, APAC, ROW.

* We provide 10% customization - Research shows that more than 40% of the times, clients do not get the specific intelligence they need in multi-client market research reports. We offer 10% customization in our reports at no extra cost. Get the exact market intelligence you require with real value for money.

* 15 pages of high level analysis including benchmarking strategies, best practices and the market's cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.

* Comprehensive market analysis for pharmaceutical and biotech companies, medical device manufacturers, pharma-research labs, doctors, physicians and hospitals, medical/pharma associations, retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered

* Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, and stakeholders?

* What are market estimates and forecasts; which markets are doing well and which are not?

* Where are the gaps and opportunities; what is driving the market?

* Which are the key playing fields? Which are the winning edge imperatives?

* How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and Analysis

The analysts working with MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

TABLE OF CONTENTS

1. INTRODUCTION

1.1. KEY TAKE AWAYS

1.2.REPORT DESCRIPTION

1.3.MARKETS COVERED

1.4.STAKEHOLDERS

1.4.1.MEDICAL DEVICE MANUFACTURERS

1.4.2.HOSPITAL SURGICAL DEPARTMENTS

1.4.3.CLINICAL RESEARCH FIRMS

1.4.4.BUSINESS RESEARCH AND CONSULTING SERVICE PROVIDERS

2. SUMMARY

3. MARKET OVERVIEW

3.1.COMPARATIVE ANALYSIS OF THE TOP TEN MEDICAL DEVICE TECHNOLOGIES

3.2.EVOLUTION OF MEDICAL DEVICE TECHNOLOGIES

3.3.DEFINING THE TOP TEN MEDICAL DEVICE TECHNOLOGIES MARKET

3.4.PHYSICIANS ADOPTING INNOVATIVE TECHNOLOGIES

3.5.AGING POPULATION DRIVES THE MARKET

3.5.1. OPPORTUNITY LIES IN LESS DEVELOPED COUNTRIES

3.6.SYNERGY BETWEEN TECHNOLOGIES GIVES BETTER OUTCOMES

3.7.PRODUCT RECALLS ARE A MAJOR CHALLENGE

4. DIAGNOSTIC IMAGING

4.1.DRIVERS

4.1.1. EMERGENCE OF NEW TECHNOLOGY

4.1.2. WIDE APPLICATION AREAS

4.1.3.AGING DEMOGRAPHICS

4.1.4.FOCUS ON PREVENTIVE HEALTHCARE

4.1.5.CMS COVERS MORE TESTS

4.2.RESTRAINTS

4.2.1.ECONOMIC SLOWDOWN

4.2.2.REGULATORY BODIES RAISE HEALTHCARE COSTS

4.3.COMPETITIVE LANDSCAPE

4.4.MRI SYSTEMS

4.4.1. DRIVERS

4.4.1.1. Wide Range of Applications

4.4.1.2.Improvement in Telsa Strength

4.4.2.COMPETITIVE LANDSCAPE

4.5.ULTRASOUND SYSTEMS

4.5.1. DRIVERS

4.5.1.1.Untapped Demand in Emerging Markets

4.5.1.2.Booming Refurbished Equipment Market for Ultrasound Systems

4.5.1.3.Increased Use of Ultrasound by EMS

4.5.2.RESTRAINTS

4.5.2.1. Saturation in Core Markets

4.5.2.2. Lack of Clear Reimbursement Policies

4.5.3.COMPETITIVE LANDSCAPE

4.6.X-RAY SYSTEMS

4.6.1.DRIVERS

4.6.1.1. Fine Image Quality

4.6.2.RESTRAINTS

4.6.2.1. Other advanced technologies hindering growth of X-ray market

4.6.2.2. High degree of Competition

4.6.3.COMPETITIVE LANDSCAPE

4.6.3.1. Mergers and Acquisitions

4.6.3.2. New X-ray Systems

4.7.MAMMOGRAPHY EQUIPMENT

4.7.1.DRIVERS

4.7.1.1. Increase in Demand

4.7.1.2. Favorable Reimbursement Scenario

4.8.TOMOGRAPHY EQUIPMENT

4.8.1.DRIVERS

4.8.1.1. Introduction of Higher Slice CT Scanner

4.8.1.2. Increase in Angiogram CT Application

4.8.1.3. Introduction of OCT

4.8.2.RESTRAINTS

4.8.2.1. Shift from a Slice Count Basis to Detector Coverage

4.8.2.2. MRI Moving Ahead of CT Scan

4.8.3.COMPETITIVE DEVELOPMENT

4.9.NUCLEAR IMAGING EQUIPMENT

4.9.1.COMPETITIVE LANDSCAPE

4.9.1.1. Other Developments

4.10.INTERVENTIONAL RADIOLOGY

4.10.1.DRIVERS

4.10.1.1. Advances in Medical Instrumentation and Radiological Imaging Technology

4.10.1.2. Minimally Invasive Imaging Procedures Gaining Popularity

4.10.2.RESTRAINTS

4.10.2.1. Financial Limitation Hinders Capital Investment

4.10.2.2. Lack of Professional Radiologists

4.11.CAPSULE ENDOSCOPY

4.11.1.DRIVERS

4.11.1.1. Increased Application of Capsule Endoscopy

4.11.1.2.FDA Clearances

4.11.2.COMPETITIVE LANDSCAPE

4.12.LASERS -- IMAGING

4.12.1.DRIVERS

4.12.1.1. Reasonable Pricing

4.12.1.2. Expansion of scope and opportunities for laser technology

5. DRUG DELIVERY DEVICES

5.1.INHALATION SYSTEMS

5.2.COMPETITIVE LANDSCAPE

5.3.INFUSION SYSTEMS

5.3.1.COMPETITIVE LANDSCAPE

5.4.NEEDLE-FREE INJECTION/TRANSDERMAL SYSTEMS

5.4.1.DRIVERS

5.5.INCREASE IN INCIDENCE OF ARTHRITIS AND HORMONE DEFICIENCY

5.6.OTHER DEVELOPMENTS IN NEEDLE-FREE INJECTION/TRANSDERMAL SYSTEMS MARKET

6. MEDICAL DIAGNOSTICS

6.1.DRIVERS

6.1.1.POPULARITY OF HOME HEALTHCARE66

6.1.2.DEMAND FOR GENETIC, MOLECULAR DIAGNOSTIC TESTING

6.2.RESTRAINTS

6.2.1.ECONOMIC SLOWDOWN AND INSURANCE ISSUES

6.3.BIOSENSORS

6.3.1.DRIVERS

6.3.1.1. Increase in Biosensor Usage Due To Multiple Applications

6.3.1.2. Unhealthy Lifestyles

6.3.1.3. Miniaturization Key to Success of Biosensors

6.3.2.RESTRAINTS

6.3.2.1. High R&D costs

6.4.IN VITRO DIAGNOSTIC (IVD)

6.4.1.DRIVERS

6.4.1.1. Demand for IVD in Emerging Markets

6.4.1.2. Increasing Need For Diagnostic Services

6.4.1.3. Increasing Accessibility of Healthcare Services

6.4.2.RESTRAINTS

6.4.2.1. Consolidation of Hospital and Commercial Laboratories

6.4.2.2. Intense FDA Scrutiny on IVD Diagnostic Market

6.5.PROTEOMICS FOR MEDICAL DIAGNOSTICS

6.5.1.DRIVERS

6.5.1.1. Proteomics Targeting More Diseases

6.5.1.2. Enables Pharmacological Profiling, Toxicity Testing

6.5.1.3. Detection of Non-communicable Diseases

6.5.2.RESTRAINTS

6.5.2.1. Protein Structuring Needs Expensive Instrumentation

6.5.2.2. Cost and Reimbursement Issues

6.5.2.3. Lack of Technologies to Speed up Validation Process

6.6.NANOTECHNOLOGY FOR MEDICAL DIAGNOSTICS

6.6.1.DRIVERS

6.6.1.1. Increase in Demand for Genetic & Preimplantation Screening

6.6.2.OPPORTUNITY

6.6.2.1. Nanotechnology for Cancer Diagnostics

6.6.3.RESTRAINT

6.6.3.1. Lack of Commercialization

6.6.3.2. Other Developments

6.7.POLYMERASE CHAIN REACTION (PCR)

6.7.1.DRIVERS

6.7.1.1. Potential to Replace Conventional Tests for Diseases

6.7.1.2. FDA Clearance for Real-Time PCR Instrumentation

6.7.2.RESTRAINTS

6.7.2.1. qPCR Technology Replacing Conventional PCR

6.7.2.2. Price sensitivity of PCR technology

6.8.ARRAYS

6.8.1.DRIVERS

6.8.1.1. Demand for Protein Array on Rise

6.8.1.2. Micro Array Technology Classifies Cancers

6.8.1.3. Minimal Use of Materials Makes Microarrays an Inexpensive Technology

7. MOBILITY AID TECHNOLOGIES

7.1.DRIVERS

7.1.1.POPULATION WITH MOBILITY ISSUES81

7.1.2.SPORTS FOR PHYSICALLY CHALLENGED GAINING POPULARITY

7.1.3.EMERGENCE OF ROBOTICS TECHNOLOGY

7.2.COMPETITIVE LANDSCAPE

7.3.GLOBAL MOBILITY AID TECHNOLOGIES MARKET BY PRODUCTS

7.3.1.WHEELCHAIRS AND RELATED DEVICES

7.3.1.1. Drivers

7.3.1.1.1. Wide Range of Designs, Materials, and Configurations

7.3.1.1.2. Increase in Demand for Power Wheelchair

7.3.1.2. Restraints

7.3.1.2.1. Power Dependence

7.3.1.2.2. Powered Assist Devices are Costly and Less Portable

7.3.1.2.3. Reimbursement Issues with Powered Wheelchairs

7.3.1.3. Competitive Landscape

7.3.2.WALKING-ASSIST DEVICES

7.4.GLOBAL MOBILITY AID DEVICE MARKET BY TECHNOLOGY

7.4.1.ROBOTICS

7.4.2.NON-ROBOTICS

8. MINIMAL INVASIVE/NON-INVASIVE SURGERY

8.1.DRIVERS

8.1.1.LESS PAINFUL AND SHORT CONVALESCENCE

8.1.2.INCREASED NEED OF SURGERIES FOR THE ELDERLY

8.1.3.HIGHER RATE OF ACCEPTANCE

8.2.RESTRAINTS

8.2.1.LIMITED NUMBER OF SURGERIES PERFORMED

8.2.2.SPECIAL TRAINING AND EQUIPMENT REQUIRED

8.3.OPPORTUNITIES

8.3.1.HUGE MARKET SIZE

8.4.STENT

8.4.1.DRIVERS

8.4.1.1. Rise in Cardiovascular Diseases

8.4.1.2. Increasing Incidence of Obesity and Diabetes

8.5.MEDICAL ROBOTICS

8.5.1.DRIVERS

8.5.1.1. Improved Surgical Results

8.5.1.2. Hospitals encourage medical robots

8.5.1.3. Cost effectiveness

8.5.2.COMPETITIVE LANDSCAPE

8.6.LASERS

8.6.1.DRIVERS

8.6.1.1. Growing Awareness

8.6.1.2. Rise in Age-Related Diseases

8.6.2.DEVELOPMENTS

8.7.BARIATRIC SURGERY

8.7.1.DRIVERS

8.7.1.1. Increasing Incidence of Weight Problems

8.7.1.2. Technological Innovation

8.7.1.3. Rising Obesity among Children

9. MICRO- FLUIDS CHIP AND MEMS

9.1.DRIVERS

9.1.1.COST-EFFECTIVE COMPLEX ANALYSIS SYSTEM

9.1.2.ESSENTIAL TOOL FOR MASS SPECTROMETRY

9.1.3.COMPLETE AUTOMATION IN A SINGLE DEVICE

9.1.4.GREATER SPEED & HIGHER QUALITY

9.1.5.MINIMAL REQUIREMENT OF SAMPLES REDUCES COST

9.2.RESTRAINTS

9.2.1.MICROFLUIDIC CHIP TECHNOLOGY CANNOT MIX FLUIDS

9.2.2.LACK OF COMMERCIALIZATION

9.3.MINIATURE MEDICAL PRESSURE SENSORS

9.4.BIOCHIPS

9.4.1.DRIVERS AND RESTRAINTS

9.4.1.1. Application of biochips in personalized medicine

9.4.1.2. Biochips help save time

9.4.1.3. Biochips aid new drug discovery

9.4.1.4. High cost associated with biochips

9.5.COMPETITIVE LANDSCAPE

9.5.1.Other developments

9.5.1.1. DNA CHIPS

9.5.2.LAB CHIPS

9.5.3.PROTEIN CHIPS

9.5.3.1. Developments

10.NON-INVASIVE MONITORING

10.1.BIOSENSORS

10.1.1.WIDE SCALE ACCEPTABILITY OF BIOSENSORS

10.1.2.HIGH COST INVOLVED IN COMMERCIALIZATION

10.1.3.CONTINUOUS GLUCOSE MONITORING

10.1.3.1. Drivers

10.1.3.1.1. Increasing incidence of diabetes

10.1.3.1.2. Convenience of non-invasive continuous glucose monitoring

11.BIOMATERIALS

11.1.INCREASE IN ORTHOPEDIC PROBLEMS

11.2.HIGH DEGREE OF REGULATORY SCRUTINY

11.3.APPLICATIONS OF BIOMATERIALS

11.4.BIONIC LIMBS

11.4.1.COMPETITIVE LANDSCAPE

11.5.BIO-COMPATIBLE MATERIALS

11.5.1.DRIVERS

11.5.1.1. Advancements in nanotechnology

11.5.1.2. Increase in demand of bio-compatible materials

11.5.2.VULCANIZED SILICON-BASED MATERIALS

11.5.3.JOINT REPLACEMENT

11.5.3.1. Drivers

11.5.3.1.1. Increasing acceptability of bone grafts substitutes

11.5.3.2. Restraints

11.5.3.2.1. Rise in prices of titanium

11.5.3.2.2. Modification in reimbursement policies

11.6.ANTIMICROBIAL WOUND DRESSING

11.6.1.DRIVERS

11.6.1.1.1. New products in anti-microbial wound dressing

11.6.1.1.2. Increasing demand in the home healthcare sector

12.BIO-IMPLANTS

12.1.GRAFT-BASED IMPLANTS

12.1.1.DRIVERS

12.1.1.1. Increasing medical acceptance of graft-based implants

12.1.1.2. Increasing popularity of cosmetic surgery

12.1.2.RESTRAINTS

12.1.2.1. Expensive bone grafts

12.2.SYNTHETIC IMPLANTS

12.2.1.DRIVERS

12.2.1.1. Wide range of applications

12.2.1.2. Synthetic implants are bio-compatible

12.2.2.NEUROSTIMULATION

12.2.2.1. Drivers

12.2.2.1.1. Increase in neurological disorders

12.2.2.1.2. Increase in demand for less complicated operating methods

12.2.2.1.3. Short treatment period

12.2.2.1.4. Technological advancements

12.2.2.2.5 The use of implantable neurostimulation devices

12.2.2.2. Opportunities

12.2.2.2.1. Wide range of innovative therapies

12.2.2.2.2. Huge market size encourages market growth

12.2.2.3. Spinal Cord Stimulation (SCS)

12.2.2.3.1. Drivers

12.2.2.3.1.1. Wide range of applications of spinal cord devices

12.2.2.3.1.2. New improved technology in spinal cord stimulator devices

12.2.2.3.2. Opportunities

12.2.2.3.2.1. FDA approval for spinal cord stimulator devices

12.2.2.4. Developments

12.2.2.5. Sacral Nerve Stimulation (SNS)

12.2.2.5.1. Drivers

12.2.2.5.1.1. Rise in number of patients

12.2.2.5.1.2. Sacral stimulation treatments facilitate increased surgical accuracy

12.2.2.5.2. Opportunities

12.2.2.5.2.1. Huge potential in Asian countries

12.2.2.6. Vagus Nerve Stimulation (VNS)

12.2.2.6.1. Drivers

12.2.2.6.1.1. Effective treatment for partial--onset seizures

12.2.2.6.2. Opportunities

12.2.2.6.2.1. Developments for VNS Market

12.2.2.6.2.2. Regulatory Approval for VNS Market

12.2.2.7. Deep Brain Stimulation Systems

12.2.2.7.1. Drivers

12.2.2.7.1.1. Improved treatments results attracting more patients

12.2.2.7.1.2. New and advanced technology provides greater flexibility to neurosurgeons

12.2.2.7.2. Restraints and Opportunities

12.2.2.7.3. Competitive Landscape

13.TELEMEDICINE

13.1.DRIVERS

13.1.1.INCREASE IN INCIDENCE OF CHRONIC DISEASES

13.1.2.COMPLEXITY OF HEALTHCARE NETWORK

13.1.3.INCREASED IT EXPENDITURE

13.1.4.SHIFTING TREND FROM TREATMENT TO EARLY INTERVENTION

13.2.RESTRAINTS

13.2.1.UNCERTAIN REIMBURSEMENT FOR TELEMEDICINE

13.2.2.LACK OF FUNDING FOR TELEMEDICINE PROGRAMS

13.2.3.TELEMEDICINE TECHNOLOGY

13.2.3.1. Hardware

13.2.3.2. Software

13.2.3.3. Network and Telecom

13.2.3.3.1. Telecom and networking market

13.2.3.3.2. Telehome T&N market

13.2.3.3.3. Telehospital/clinics T&N market

14.TOP TEN MEDICAL DEVICE TECHNOLOGIES PATENT ANALYSIS

14.1.GENERAL TRENDS

15.COMPANY PROFILES

15.1.ABBOTT LABORATORIES

15.1.1.OVERVIEW

15.1.2.DEVELOPMENTS

15.2.ATRIUM MEDICAL CORPORATION

15.2.1.OVERVIEW

15.2.2.DEVELOPMENTS

15.3.BOSTON SCIENTIFIC

15.3.1.OVERVIEW

15.3.2.DEVELOPMENTS

15.4.BERCHTOLD CORPORATION (SUBSIDIARY OF BERCHTOLD GMBH & CO. KG)

15.4.1.OVERVIEW & PRODUCTS

15.5.CONOR MEDSYSTEMS, LLC

15.5.1.OVERVIEW

15.5.2.DEVELOPMENTS

15.6.CELONOVA BIOSCIENCES INC

15.6.1.OVERVIEW

15.6.2.DEVELOPMENTS

15.7.ETHICON ENDO-SURGERY

15.7.1.OVERVIEW & DEVELOPMENTS

15.8.INTROMEDIC

15.8.1.OVERVIEW & PRODUCT

15.8.2.DEVELOPMENTS

15.9.HITACHI MEDICAL CORPORATION

15.9.1.OVERVIEW

15.9.2.DEVELOPMENTS

15.10.GIVEN IMAGING

15.10.1. OVERVIEW

15.10.2. DEVELOPMENTS

15.11. GE HEALTHCARE

15.11.1. OVERVIEW

15.11.2. DEVELOPMENTS

15.12.BIOMET, INC

15.12.1. OVERVIEW

15.12.2. DEVELOPMENTS

15.13.SIEMENS MEDICAL SOLUTIONS

15.13.1. OVERVIEW

15.13.2. DEVELOPMENTS

15.14.XTENT, INC.

15.14.1. OVERVIEW & PRODUCTS

15.15.VALLEYLAB

15.15.1. OVERVIEW

15.16.TERUMO MEDICAL CORPORATION

15.16.1. OVERVIEW

15.16.2. DEVELOPMENTS

15.17.MIV THERAPEUTICS, INC.

15.17.1. OVERVIEW

15.17.2. DEVELOPMENTS

15.18.ORBUSNEICH

15.18.1. OVERVIEW & DEVELOPMENTS

15.19.STENTYS S.A.S.

15.19.1. OVERVIEW & DEVELOPMENTS

15.20.MEDINOL LTD.

15.20.1. OVERVIEW

15.20.2. DEVELOPMENTS

15.21.PROSURGICS

15.21.1. OVERVIEW

15.21.2. DEVELOPMENTS

15.22.ROCHE

15.22.1. OVERVIEW

15.22.2. R&D INNOVATIONS

15.23.OLYMPUS

15.23.1. OVERVIEW

15.23.2. DEVELOPMENTS

15.24.MEDTRONIC, INC.

15.24.1. OVERVIEW

15.24.2. DEVELOPMENTS

15.25.SCIENTIFIC INTAKE CO LTD

15.26.SATIETY, INC

15.27.METACURE NV

15.28.LEPTOS BIOMEDICAL, INC.

15.29.SMITH & NEPHEW

15.29.1. OVERVIEW

15.29.2. DEVELOPMENTS

15.30.ENDOART SA

15.31.INTUITIVE SURGICAL, INC

15.31.1. PRODUCTS

15.31.2. DEVELOPMENTS

15.32.ALLERGAN

15.32.1. OVERVIEW

15.33.ENTEROMEDICS

15.33.1. OVERVIEW & PRODUCTS

15.34.HELIOSCOPIE SA

15.34.1. OVERVIEW

15.35.KARL-STORZ GMBH & CO. KG

15.35.1. RECENT DEVELOPMENTS

15.36.BARONOVA, INC.

15.36.1. OVERVIEW & PRODUCTS

15.37.ESAOTE SPA

15.37.1. OVERVIEW

15.37.2. DEVELOPMENTS

15.38.STRYKER

15.38.1. OVERVIEW

15.38.2. EVELOPMENTS

APPENDIX

To order this report:

Reportlinker Adds Top 10 Medical Device Technology